D-0229-2025 Class II Ongoing

Recalled by AvKARE — Pulaski, TN

FDA drug recall D-0229-2025 was initiated by AvKARE on Feb 4, 2025 and is designated Class II. Reason for recall: Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%) The recall status is ongoing. Affected quantity: 1266 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 26, 2025
Initiation Date
Feb 4, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1266 bottles

Product description

Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN 38478, Manufactured by: Amneal Pharmaceuticals of NY, LLC, NY 11719, NDC 42291-778-90

Reason for recall

Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)

Distribution pattern

USA Nationwide

Code information

Lot#: BC20223A, Exp. March 31, 2025.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0229-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0229-2025. Report a data issue: hello@regdatalab.com.